In Q2, the FDA approved two biosimilars in the ustekinumab and bevacizumab markets and four biosimilars were launched within ...

Solana ETF odds have skyrocketed to 99% on prediction markets after the SEC called for fast-tracked S-1 revisions from issuers, stoking bullish momentum. Traders are now eyeing whether ETF-driven ...

Chipotle Mexican Grill's organic growth cadence arising from the rich cash flows remains highly compelling. Click here to ...

Celestica released its FQ2 2025 earnings just recently and it was a dual beat once again. The positive bottom-line surprise ...

Shares of Spotify (NYSE:SPOT) slid 7.4% in premarket trading on Tuesday after the music and podcast streaming platform provided a weaker-than-expected forecast for the current quarter and missed on ...

Q3 sales increased 3% and organic sales increased 6%* Q3 GAAP EPS of $0.94; Q3 Adjusted EPS* of $1.05 Q3 orders increased 2% organically year-over-year Systems and Services backlog of $14.6 ...